|
13 Nov 2019 |
COI Pharmaceuticals Announces Acquisition of Calporta by Merck
|
|
12 Nov 2019 |
bluebird bio and Forty Seven Announce a Research Collaboration to Study an All Antibody Conditioning Regimen for Use in Combination with Autologous Lentiviral Vector Hematopoietic Stem Cell Gene Therapy
|
|
11 Nov 2019 |
Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
|
|
11 Nov 2019 |
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
|
|
09 Nov 2019 |
Akeso, Inc. Completed Series-D Private Financing for close to US$150 Million
|
|
09 Nov 2019 |
Ningbo Tai Kang Medical Technology Co., Ltd Announces Global Licensing Agreement With AstraZeneca
|
|
07 Nov 2019 |
Bayer invests USD 50 Million in eGenesis Series B financing round
|
|
07 Nov 2019 |
Novo Nordisk obtains exclusive worldwide licence to potential NASH candidate UD-014 from UBE Industries
|
|
07 Nov 2019 |
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
|
|
07 Nov 2019 |
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
|
|
07 Nov 2019 |
Alvotech and STADA Agree on Strategic Biosimilar Partnership
|
|
06 Nov 2019 |
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
|
|
06 Nov 2019 |
Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate
|
|
06 Nov 2019 |
Ark Biosciences Reports Successful Completion of Phase II Proof-of-Concept Clinical Trial of Ziresovir for Treatment of Infants Hospitalized with Respiratory Syncytial Virus (RSV) Infection
|
|
06 Nov 2019 |
Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
|
|
06 Nov 2019 |
Allogene Therapeutics and Notch Therapeutics Announce Collaboration to Research and Develop Induced Pluripotent Stem Cell (iPSC)-Derived Allogeneic Therapies for Hematologic Cancer Indications
|
|
05 Nov 2019 |
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China
|
|
05 Nov 2019 |
BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
|
|
01 Nov 2019 |
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
|
|
01 Nov 2019 |
Dicerna Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection
|
|
31 Oct 2019 |
Pandion and Astellas Announce Collaboration to Deliver Pancreas-Targeted Immunomodulators
|
|
30 Oct 2019 |
LEO Pharma enters into option agreement with Ubiquigent for access to novel compounds
|
|
29 Oct 2019 |
Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
|
|
28 Oct 2019 |
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program
|
|
28 Oct 2019 |
Molecular Targeting Technologies, Inc. Receives Global Rights From NIH for Integrin-Targeting Radiotherapeutics to Treat GBM and Lung Cancer
|
